qart-medical.com
About company
Q-ART (Quantitative Assisted Reproductive Technologies) Medical is a clinical-stage MedTech company that addresses the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF). They aim to create a new and better gold standard in the ART market. The QART system aims to improve the current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging, provide quantitative DNA integrity information, on a cell-by-cell basis, and automatically sort a semen sample according to objective consensus criteria. Q-ART Medical was founded by co-founders Alon Shalev and Prof. Natan T. Shaked.
